Predict your next investment

BUSINESS PRODUCTS & SERVICES | Advertising, Marketing & PR

See what CB Insights has to offer

Founded Year



Merger | Merged

About Adaptive

Adaptive is a marketing and branding agency that focuses on the insurance industry.

Adaptive Headquarter Location

Charlottesville, Virginia,

United States


Latest Adaptive News

10th annual Adaptive Designs in Clinical Trials

Nov 8, 2017

10th annual Adaptive Designs in Clinical Trials SMi Group 04/09/2018 - 04/10/2018 LONDON Now running for 10 years, SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 9th and 10th April 2018. The programme is now live on . This year’s agenda has been curated to provide you with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development. Giving you a fresh take on this vital area of biopharma, the event will ride the wave of technology within the pharmaceutical industry, as we consider how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies. Featured Speakers include: Alex Sverdlov, Director, Statistical Scientist, Novartis Frank Fleisher, Principal Methodology Statistician, Boehringer-Ingelheim Christine Fletcher, Executive Director Biostatistics, Amgen Chris Harbron, Principal Statistical Scientist, Roche Olivier Collignon, Biostatistician, European Medicines Agency Beatrice Panico, Medical Advisor, MHRA Corine Baayen, Senior Biostatistician, H.Lundbeck Key Highlights Hear exciting case studies on enrichment designs and group sequential trials Discover how big pharma companies are using Platform Trials and self-adapting priors to advance their adaptive clinical trials Examine the use of adaptive clinical trials are used to produce targeted therapies Learn from the latest regulatory perspectives from MHRA and EMA, including planning and assessing umbrella and basket trials Early Bird: Book by Dec 15 to save £400. Book by Jan 31 to save £200. Book by 28 Feb to save £100.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.